Cardinal Health, Inc. (CAH)

Over the past six months, Cardinal Health's stock (CAH) has experienced positive momentum, with the stock price increasing by approximately 74.12% between January 2, 2025, and December 31, 2025. Key events impacting the stock include Q1 FY2026 Earnings Beat, which led to a 15.43% increase in shares. Cardinal Health raised its fiscal 2026 non-GAAP diluted EPS outlook to at least $10.00. The completion of the Solaris Health acquisition added over 750 providers to its MSO platform. An announcement regarding a new Indianapolis distribution facility supported network expansion. Several analysts have upgraded Cardinal Health's stock and raised their price targets.

Demand for some of Cardinal Health's products and services exhibits seasonality. The company has implemented an inventory reserve program for respiratory diagnostics to help labs and health systems pre-order products more accurately before the onset of the seasonal flu, strep, and RSV. Macro-level demand for medical supplies is expected to continue growing.

Cardinal Health, Inc. is an American multinational healthcare services and products company headquartered in Dublin, Ohio, operating primarily within the healthcare sector. It specializes in the distribution of pharmaceuticals and medical products, serving as a nationwide drug distributor and a provider of services to pharmacies, healthcare providers, and manufacturers. The company operates through two main segments: Pharmaceutical and Medical. In its Pharmaceutical segment, Cardinal Health is the second-largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. The Medical segment manufactures and distributes a wide array of medical and surgical products. Cardinal Health serves over 100,000 locations and provides medical products to over 75% of hospitals in the United States.

Cardinal Health has a significant global presence, serving customers in the U.S., Canada, Europe, South America, and the Asia/Pacific region. The company's headquarters are in Dublin, Ohio, U.S., and it maintains a broad network of offices and facilities across the globe, contributing to its extensive market reach.

There is no specific information detailing events that have negatively impacted Cardinal Health, Inc.'s brand reputation in the past year. The company's recent news focuses on positive financial performance, strategic acquisitions, and expanded services, suggesting a generally stable or improving reputation in the recent past.

Cardinal Health's stock ownership is a mix of institutional, retail, and individual investors. Institutional investors hold a significant portion, with approximately 64.51% to 88.38% of the company's stock. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and State Street Corp. Insiders own approximately 0.24% of the stock, while public companies and individual investors (retail investors) hold around 29.55% to 35.25%.